Cardiology Measures 2026

  • QPP 5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  • QPP 6: Coronary Artery Disease (CAD): Antiplatelet Therapy
  • QPP 7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
  • QPP 8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  • QPP 39: Screening for Osteoporosis for Women Aged 65-85 Years of Age
  • QPP 47: Advance Care Plan
  • QPP 118: Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
  • QPP 130: Documentation of Current Medications in the Medical Record
  • QPP 187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy
  • QPP 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • QPP 236: Controlling High Blood Pressure
  • QPP 238: Use of High-Risk Medications in Older Adults
  • QPP 243: Cardiac Rehabilitation Patient Referral from an Outpatient Setting
  • QPP 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
  • QPP 326: Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
  • QPP 344: Rate of Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)
  • QPP 374: Closing the Referral Loop: Receipt of Specialist Report
  • QPP 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
  • QPP 438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
  • QPP 441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)
  • QPP 493: Adult Immunization Status
  • QPP 495: Ambulatory Palliative Care Patients’ Experience of Feeling Heard and Understood
  • QPP 503: Gains in Patient Activation Measure (PAM) Scores at 12 Months
  • AVBC2: Echocardiogram Stewardship in Congestive Heart Failure (CHF): Avoiding Repeat Tests without Clinical Indication
  • AVBC3: SGLT2 Inhibitors for Patients with Chronic Kidney Disease (CKD) with or without Type 2 Diabetes Mellitus
  • AVBC4: Noninvasive Ischemic Imaging Stewardship in Chronic Coronary Disease: Avoiding Testing without Clinical Indication